Skip to content

Clinical trials

Purpura, Thrombocytopenic, Idiopathic trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Country / region: Netherlands Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20091
20111
20122
20131
20143
20182
20191
20202
20211
20221
20231
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting4
Active, not recruiting1
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Chugai Pharmaceutical2
Eisai Inc.2
GlaxoSmithKline2
Principia Biopharma, a Sanofi Company2
Rigel Pharmaceuticals2
Takeda2
argenx2
Amgen1
Bioverativ, a Sanofi company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic23
Thrombocytopenia6
Purpura5
Hemorrhage3
Antiphospholipid Syndrome2
Autoimmune Diseases2
Behcet Syndrome2
Blood Platelet Disorders2
Cytopenia2
Dermatomyositis2

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.